BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 8274159)

  • 1. Cytochrome P450 dependent N-hydroxylation of a guanidine (debrisoquine), microsomal catalysed reduction and further oxidation of the N-hydroxy-guanidine metabolite to the urea derivative. Similarity with the oxidation of arginine to citrulline and nitric oxide.
    Clement B; Schultze-Mosgau MH; Wohlers H
    Biochem Pharmacol; 1993 Dec; 46(12):2249-67. PubMed ID: 8274159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microsomal formation of nitric oxide and cyanamides from non-physiological N-hydroxyguanidines: N-hydroxydebrisoquine as a model substrate.
    Clement B; Boucher JL; Mansuy D; Harsdorf A
    Biochem Pharmacol; 1999 Aug; 58(3):439-45. PubMed ID: 10424762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-hydroxylation of the antiprotozoal drug pentamidine catalyzed by rabbit liver cytochrome P-450 2C3 or human liver microsomes, microsomal retroreduction, and further oxidative transformation of the formed amidoximes. Possible relationship to the biological oxidation of arginine to NG-hydroxyarginine, citrulline, and nitric oxide.
    Clement B; Jung F
    Drug Metab Dispos; 1994; 22(3):486-97. PubMed ID: 8070328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microsomal cytochrome P450 dependent oxidation of N-hydroxyguanidines, amidoximes, and ketoximes: mechanism of the oxidative cleavage of their C=N(OH) bond with formation of nitrogen oxides.
    Jousserandot A; Boucher JL; Henry Y; Niklaus B; Clement B; Mansuy D
    Biochemistry; 1998 Dec; 37(49):17179-91. PubMed ID: 9860831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytochrome P450 catalyzes the oxidation of N omega-hydroxy-L-arginine by NADPH and O2 to nitric oxide and citrulline.
    Boucher JL; Genet A; Vadon S; Delaforge M; Henry Y; Mansuy D
    Biochem Biophys Res Commun; 1992 Sep; 187(2):880-6. PubMed ID: 1530643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytochrome P450-dependent N-hydroxylation of an aminoguanidine (amidinohydrazone) and microsomal retroreduction of the N-hydroxylated product.
    Clement B; Schultze-Mosgau MH; Richter PH; Besch A
    Xenobiotica; 1994 Jul; 24(7):671-88. PubMed ID: 7975731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic monooxygenase activities in subjects with a genetic defect in drug oxidation.
    Meier PJ; Mueller HK; Dick B; Meyer UA
    Gastroenterology; 1983 Sep; 85(3):682-92. PubMed ID: 6603386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidations of N(omega)-hydroxyarginine analogues and various N-hydroxyguanidines by NO synthase II: key role of tetrahydrobiopterin in the reaction mechanism and substrate selectivity.
    Moali C; Boucher JL; Renodon-Corniere A; Stuehr DJ; Mansuy D
    Chem Res Toxicol; 2001 Feb; 14(2):202-10. PubMed ID: 11258969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of cytochrome b5 in the oxidation of testosterone and nifedipine by recombinant cytochrome P450 3A4 and by human liver microsomes.
    Yamazaki H; Nakano M; Imai Y; Ueng YF; Guengerich FP; Shimada T
    Arch Biochem Biophys; 1996 Jan; 325(2):174-82. PubMed ID: 8561495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of cytosolic superoxide dismutase as a stimulator in anthranilamide hydroxylation by a microsomal monooxygenase system in rat liver.
    Ohta Y; Ishiguro I; Naito J; Shinohara R
    J Biochem; 1984 Nov; 96(5):1323-36. PubMed ID: 6441802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation.
    Mani C; Gelboin HV; Park SS; Pearce R; Parkinson A; Kupfer D
    Drug Metab Dispos; 1993; 21(4):645-56. PubMed ID: 8104124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Redox cycling of resorufin catalyzed by rat liver microsomal NADPH-cytochrome P450 reductase.
    Dutton DR; Reed GA; Parkinson A
    Arch Biochem Biophys; 1989 Feb; 268(2):605-16. PubMed ID: 2464338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Requirements for cytochrome b5 in the oxidation of 7-ethoxycoumarin, chlorzoxazone, aniline, and N-nitrosodimethylamine by recombinant cytochrome P450 2E1 and by human liver microsomes.
    Yamazaki H; Nakano M; Gillam EM; Bell LC; Guengerich FP; Shimada T
    Biochem Pharmacol; 1996 Jul; 52(2):301-9. PubMed ID: 8694855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic biotransformation of parathion: role of cytochrome P450 in NADPH- and NADH-mediated microsomal oxidation in vitro.
    Murray M; Butler AM
    Chem Res Toxicol; 1994; 7(6):792-9. PubMed ID: 7696534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidation of N-hydroxyguanidines by cytochromes P450 and NO-synthases and formation of nitric oxide.
    Mansuy D; Boucher JL
    Drug Metab Rev; 2002 Aug; 34(3):593-606. PubMed ID: 12214669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidation of tricyclic antidepressant drugs, debrisoquine and 7-ethoxyresorufin, by human liver preparations.
    von Bahr C; Birgersson C; Morgan ET; Eriksson O; Göransson M; Spina E; Woodhouse K
    Xenobiotica; 1986 May; 16(5):391-400. PubMed ID: 3739365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytochrome P450 isozymes catalyzing 4-hydroxylation of parkinsonism-related compound 1,2,3,4-tetrahydroisoquinoline in rat liver microsomes.
    Suzuki T; Fujita S; Narimatsu S; Masubuchi Y; Tachibana M; Ohta S; Hirobe M
    FASEB J; 1992 Jan; 6(2):771-6. PubMed ID: 1537468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolite intermediate complexation of microsomal cytochrome P450 2C11 in male rat liver by nortriptyline.
    Murray M
    Mol Pharmacol; 1992 Nov; 42(5):931-8. PubMed ID: 1435757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Particular ability of liver P450s3A to catalyze the oxidation of N omega-hydroxyarginine to citrulline and nitrogen oxides and occurrence in no synthases of a sequence very similar to the heme-binding sequence in P450s.
    Renaud JP; Boucher JL; Vadon S; Delaforge M; Mansuy D
    Biochem Biophys Res Commun; 1993 Apr; 192(1):53-60. PubMed ID: 7682811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic conversion of the novel Src kinase inhibitor [7-(2,6-dichloro-phenyl)-5-methyl-benzo[1,2,4]triazin-3-yl]-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-amine (TG100435) and Its N-oxide metabolite by flavin-containing monoxygenases and cytochrome P450 reductase.
    Kousba A; Soll R; Yee S; Martin M
    Drug Metab Dispos; 2007 Dec; 35(12):2242-51. PubMed ID: 17881660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.